Irish ‘Lipitor’ litigation: High Court favours broad claim construction

摘要

In its first significant judgment on claim construction in over 25 years, Ireland's High Court approved the principles laid down by the English House of Lords in Kirin-Amgen, holding that Warner-Lambert's ‘Lipitor’ patent is not limited to a racemic mixture and refusing Ranbaxy a declaration of non-infringement.